Biosergen AB (BIOSGN.ST) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+34.2%

SEK 0.66

vs SEK 0.49 price

Levered DCF

SEK 0.72

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

-8.67

Distress zone

Rating

—

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-20.76×	-60.49×	-7.78×	-5.2×	-40.62×	-129.8×	-1,288.13×
P/B	72.03×	24.08×	99.13×	13.12×	68.73×	-80.32×	-1,490.77×
P/S	0×	0×	0×	0×	162.21×	197.97×	5,322.79×
EV / EBITDA	-20.37×	-57.85×	911.76×	-7.92×	-39.89×	-130.4×	-37,172.98×
Gross margin	0.0%	0.0%	0.0%	0.0%	-2.5%	-137.5%	100.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	-393.2%	-140.5%	-392.4%
Net margin	0.0%	0.0%	0.0%	0.0%	-400.3%	-151.7%	-412.5%
Current ratio	2.46×	14.25×	1.42×	3.07×	3.19×	0.31×	0.59×
Debt / equity	0×	0×	0×	0×	0×	0×	-1.41×
Interest coverage	-4,139.3×	0×	0×	-632.02×	-140.44×	0×	-67.52×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-347.0%	-39.8%	-1277.7%	-149.4%	-169.6%	61.6%	115.5%
Return on invested capital	-351.9%	-42.1%	-1288.5%	-149.1%	-166.6%	57.0%	-72.3%
Return on assets	-205.9%	-36.3%	-375.5%	-100.8%	-116.4%	-140.2%	-81.2%
Free cash flow yield	-4.3%	-1.4%	-15.5%	-9.8%	-2.7%	-0.5%	-0.0%
Earnings yield	-4.8%	-1.7%	-12.9%	-11.4%	-2.5%	-0.8%	-0.1%
Enterprise value	SEK 831.9M	SEK 1.1B	SEK 207.9M	SEK 269.7M	SEK 1.4B	SEK 876.8M	SEK 7B
Net debt / EBITDA	0.38×	2.64×	-8.26×	0.86×	0.63×	0.09×	-7.4×
Cash conversion cycle (days)	0	0	-1,359	-8,879	-11,396	-77	408